Literature DB >> 10518566

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

E Gonzalez1, M Bamshad, N Sato, S Mummidi, R Dhanda, G Catano, S Cabrera, M McBride, X H Cao, G Merrill, P O'Connell, D W Bowden, B I Freedman, S A Anderson, E A Walter, J S Evans, K T Stephan, R A Clark, S Tyagi, S S Ahuja, M J Dolan, S K Ahuja.   

Abstract

Genetic variation in CC chemokine receptor 5 (CCR5), the major HIV-1 coreceptor, has been shown to influence HIV-1 transmission and disease progression. However, it is generally assumed that the same CCR5 genotype (or haplotype) has similar phenotypic effects in different populations. To test this assumption, we used an evolutionary-based classification of CCR5 haplotypes to determine their associated HIV-1 disease-modifying effects in a large well-characterized racially mixed cohort of HIV-1-seropositive individuals. We demonstrate that the spectrum of CCR5 haplotypes associated with disease acceleration or retardation differs between African Americans and Caucasians. Also, we show that there is a strong interactive effect between CCR5 haplotypes with different evolutionary histories. The striking population-specific phenotypic effects associated with CCR5 haplotypes emphasize the importance of understanding the evolutionary context in which disease susceptibility genes are expressed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518566      PMCID: PMC18402          DOI: 10.1073/pnas.96.21.12004

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Authors:  P A Zimmerman; A Buckler-White; G Alkhatib; T Spalding; J Kubofcik; C Combadiere; D Weissman; O Cohen; A Rubbert; G Lam; M Vaccarezza; P E Kennedy; V Kumaraswami; J V Giorgi; R Detels; J Hunter; M Chopek; E A Berger; A S Fauci; T B Nutman; P M Murphy
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Lack of evidence for human or simian T-lymphotropic viruses type III infection in pygmies.

Authors:  F Brun-Vezinet; G Jaeger; C Rouzioux; M A Rey; M C Dazza; S Chamaret; L Montagnier; G Charmot
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

3.  The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

Authors:  Y Huang; W A Paxton; S M Wolinsky; A U Neumann; L Zhang; T He; S Kang; D Ceradini; Z Jin; K Yazdanbakhsh; K Kunstman; D Erickson; E Dragon; N R Landau; J Phair; D D Ho; R A Koup
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

4.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.

Authors:  F Gao; E Bailes; D L Robertson; Y Chen; C M Rodenburg; S F Michael; L B Cummins; L O Arthur; M Peeters; G M Shaw; P M Sharp; B H Hahn
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

6.  Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa.

Authors:  N K Saksena; V Herve; J P Durand; B Leguenno; O M Diop; J P Digouette; C Mathiot; M C Muller; J L Love; S Dube
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

7.  Prevalence of hepatitis C virus and other blood-borne viruses in Pygmies and neighbouring Bantus in southern Cameroon.

Authors:  M P Kowo; P Goubau; E C Ndam; O Njoya; S Sasaki; V Seghers; H Kesteloot
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Sep-Oct       Impact factor: 2.184

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Infections among pygmies in the Eastern Province of Cameroon.

Authors:  P M Ndumbe; G Atchou; M Biwole; V Lobe; J Ayuk-Takem
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

10.  Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission.

Authors:  I J Koralnik; E Boeri; W C Saxinger; A L Monico; J Fullen; A Gessain; H G Guo; R C Gallo; P Markham; V Kalyanaraman
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  94 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

3.  Human population genetic structure and inference of group membership.

Authors:  Michael J Bamshad; Stephen Wooding; W Scott Watkins; Christopher T Ostler; Mark A Batzer; Lynn B Jorde
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

4.  A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.

Authors:  Michael J Bamshad; Srinivas Mummidi; Enrique Gonzalez; Seema S Ahuja; Diane M Dunn; W Scott Watkins; Stephen Wooding; Anne C Stone; Lynn B Jorde; Robert B Weiss; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

5.  Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.

Authors:  Timothy J Henrich; Nicolas R P Lewine; Sun-Hee Lee; Suhas S P Rao; Reem Berro; Roy M Gulick; John P Moore; Athe M N Tsibris; Daniel R Kuritzkes
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

6.  A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.

Authors:  Lidan Xu; Yuandong Qiao; Xuelong Zhang; Haiming Sun; Jingwei Wang; Donglin Sun; Xueyuan Jia; Chao Shen; Yanling Zhao; Yan Jin; Yang Yu; Hong Ling; Kaili Wang; Songbin Fu
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

7.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.

Authors:  Janelle R Salkowitz; Shannon E Bruse; Howard Meyerson; Hernan Valdez; Donald E Mosier; Clifford V Harding; Peter A Zimmerman; Michael M Lederman
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

8.  Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates.

Authors:  Gabriel Catano; Zoya A Chykarenko; Andrea Mangano; J-M Anaya; Weijing He; Alison Smith; Rosa Bologna; Luisa Sen; Robert A Clark; Andrew Lloyd; Ludmila Shostakovich-Koretskaya; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

9.  Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.

Authors:  Wildeman Zapata; Wbeimar Aguilar-Jiménez; Nicolás Pineda-Trujillo; Winston Rojas; Hernando Estrada; María T Rugeles
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-09       Impact factor: 2.205

10.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Authors:  Trevor D Burt; Brian K Agan; Vincent C Marconi; Weijing He; Hemant Kulkarni; Jeffrey E Mold; Marielle Cavrois; Yadong Huang; Robert W Mahley; Matthew J Dolan; Joseph M McCune; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.